JPRN-UMIN000001411已完成未知
Clinical pharmacology and pharmacogenetic study on the clinical response for tamoxifen - Clinical pharmacology and pharmacogenetics of tamoxifen
Saitama Medical University, Saitama International Medical Center0 个研究点目标入组 100 人开始时间: 2008年10月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Tamoxifen contraindication. Patients with (possibly) pregnant, with lactation. Patients possibly suffering from allergic reaction, severe liver or kidney dysfunction. 2. Patients who are judged by doctors as inadequate to enroll this study.
研究者
相似试验
已完成
不适用
Research of pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of 5-Fluorouracil in colorectal cancer patientsColorectal cancerJPRN-UMIN000004095Department of clinical pharmacokinetics, Graduate school of Pharmaceutical Science, Kyushu University30
招募中
2 期
A clinical trial to evaluate the effect of an Ayurvedic medicine, varyadi kashaya in patients with raised blood levels of uric acid.CTRI/2023/03/050452INSTITUTE OF POST GRADUATE AYURVEDIC EDUCATION AND RESEARCH AT S.V.S.P.
已完成
不适用
Pharmacokinetics and pharmacogenomics study with erlotinib in the treatment of advanced non-small cell lung cancer (NSCLC)on-small cell lung cancerJPRN-UMIN000006634Department of Respiratory Medicine / Keio Cancer Center, School of Medicine, Keio University40
进行中（未招募）
不适用
Aspects Pharmacogénétiques et Pharmacocinétiques de la réponse à la CHimiothérapie d’induction par Docetaxel, Cisplatine et 5-Fluorouracile (TPF), des cancers OREUCTR2008-006874-14-FRCHU de Nîmes
尚未招募
1 期
The Pharmacogenetic and Pathological Assessment of CYP2C19 Activity in Patients with Advanced CancerAdvanced cancerCancer -ACTRN12605000393651Cancer Trials New Zealand50